Clinical differences between hospitalized patients with COVID-19-related pneumonia and those with influenza-related pneumonia during the omicron variant surge

Table 1.

Patients’ background characteristics by group

COVID-19 pneumonia Flu pneumonia p value

Patients number 46 (46/285 =15.5%) 6 (6/12=50.0%) 0.002**
Male/Female 33/13 (Male :71.7%) 5/1 (Male:83.3%) 0.547
Age, years old 75.5 (45-93) 53.8 (19-73) 0.002**
Underlying diseases
Diabetes mellitus 7 (15.2%) 3 (50.0%) 0.042*
Solid malignant tumor 6 (13.0%) 0 0.3469
Brain stroke 6 (13.0%) 1 (1.7%) 0.806
Dementia 5 (10.9%) 1 (1.7%) 0.676
Heart diseases 4 (8.7%) 1 (1.7%) 0.533
Neurological diseases 4 (8.7%) 0 0.452
Mental disorders 2 (4.3%) 0 0.602
Hematological diseases 2 (4.3%) 1 (1.7%) 0.543
AIDS 1 (2.2%) 0 0.715
Rheumatoid arthritis 1 (2.2%) 0 0.715
Chronic lung diseases 1 (2.2%) 1 (1.7%) 0.259
Kidney diseases 1 (2.2%) 0 0.715
Infection route
Clusters (Facilities) 9 (19.6%) 0 0.233
Inpatients 5 (10.9%) 2 (33.3%) 0.129
Nursing visit service 4 (8.7%) 0 0.452
Home 4 (8.7%) 1 (16.7%) 0.533
Work 2 (4.3%) 2 (33.3%) 0.012*
Unknown 22 (47.8%) 1 (16.7%) 0.148
Vaccination
5 times< 4 (8.7%) NA
4 times 5 (10.9%) NA
3 times 6 (13.0%) NA
Twice 7 (15.2%) NA
Once 0 2 (33.3%) 0.304
None 8 (17.3%) 4 (66.7%) 0.007**
  Unknown 16 (34.8%) 0 0.008